DNAAF4

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, DNAAF4 mutation is significantly associated with the drug of many other genes, with 14 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible DNAAF4-associated genes across cancer lineages are Savolitinib, Quizartinib, and GSK2110183B. Each is linked with DNAAF4 in more than 1 cancer types. Because this analysis shows association rather than direction, both DNAAF4-to-partner and partner-to-DNAAF4 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Savolitinib grouped by DNAAF4-low versus DNAAF4-high in LARGE_INTESTINE.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (DNAAF4→partner) and Y-score (partner→DNAAF4) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LARGE_INTESTINESavolitinib →+0.415+2.777.020.03832
LARGE_INTESTINEQuizartinib →+0.382+2.874.011.02131
LARGE_INTESTINEGSK2110183B →+0.604+2.871.036.02121
LARGE_INTESTINETL-2-105 →+0.516+2.874.004.02121
LARGE_INTESTINEGSK429286A →+0.327+2.874.027.02121
LARGE_INTESTINEGSK690693 →+0.561+2.874.019.02121
Each partner links to its Q-omics profile. Showing the 6 strongest of 14 associations by consensus.

Savolitinib by DNAAF4 expression — LARGE_INTESTINE

Box plot of Savolitinib in DNAAF4-low vs DNAAF4-high samples in LARGE_INTESTINE.

Explore this box plot interactively →

Exploration